Pharmacies and Drug Control
Pharmacies, pharmacists, and wholesale drug distributors face a complex web of state and federal licensing laws and regulations.
Our team’s deep understanding of the legal nuances can help you navigate commercial and federal healthcare program payor guidelines, laws and regulations pertaining to handling of controlled substances, and regulations for participation in the NPIA “own use” and 340B pricing programs.
We can help you understand the requirements and comply with the following:
- State board of pharmacy licensure and compliance
- DEA registration requirements
- DEA requirements for the purchase, sale, and custody of controlled substances
- Robinson-Patman Act anti-price discrimination parameters
- Nonprofit Institutions Act, or “own use” requirements
- 340B Drug Pricing Program participation and compliance
- Prescription Drug Marketing Act or PDMA requirements
Contact
View All ProfessionalsRelated

Check’s in the Mail: HRSA Tests a New Script for 340B
HRSA has announced a new 340B Rebate Model Pilot Program, marking a significant shift in how the…

Dykema Advises Wellgistics Health, Inc. on Nasdaq IPO
Congratulations to Dykema’s client, Wellgistics Health, Inc. (Nasdaq: WGRX), on the successful…

The Doctor Will Stream You Now: DEA’s Proposed Telemedicine Framework
On January 17, 2025, the U.S. Drug Enforcement Administration (“DEA”) published a notice of proposed…